Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

The document cannot be parsed.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Telogen effluvium is a type of hair loss that happens when stress or illness causes many hairs to enter the resting phase and fall out.

Tithonia diversifolia extract improved digestion but didn't enhance lamb growth.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Low levels of ferritin and vitamin B12 are common in women with telogen effluvium, but the link between nutrient deficiencies and the condition is not clear.

Tofacitinib effectively treats Alopecia Areata.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tissue expansion surgery generally improves quality of life in children, especially for scars and alopecia.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen effluvium is a condition where hair falls out due to various factors like illness, stress, or nutrient deficiency.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.